<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Rao, Neal M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Linking sICH Definitions to Outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">Patients with symptomatic intracranial hemorrhage (sICH) have an increased risk of a poor or fatal outcome [Strbian D et al. Neurology 2011]. However, the direct comparison of sICH rates between different thrombolysis studies is complicated by varying definitions of sICH [Gumbinger C. et al. Stroke 2012]. This article discusses results from a study on the most accurate definition of clinically relevant hemorrhagic transformation after thrombolytic therapy for stroke with IV tissue plasminogen activator.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>